Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Hartley

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Protein Engineering, Design & Selection : PEDS|January 8, 2008
Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4Hubert Gaertner, Olivier Lebeau, Irène Borlat, et al.
Biophysical Journal|August 19, 2019
High-Affinity Binding of Chemokine Analogs that Display Ligand Bias at the HIV-1 Coreceptor CCR5Carlos A Rico, Yamina A Berchiche, Mizuho Horioka, et al.
Science (New York, N.Y.)|October 16, 2004
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5Michael M Lederman, Ronald S Veazey, Robin Offord, et al.
Clinical & Translational Immunology|December 21, 2020
Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general populationNicolas Vuilleumier, Panagiotis Antiochos, Pedro Marques-Vidal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2023
Influenza A virus exploits transferrin receptor recycling to enter host cellsBeryl Mazel-Sanchez, Chengyue Niu, Nathalia Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2004
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitorsOliver Hartley, Hubert Gaertner, Jill Wilken, et al.
Scientific Reports|July 12, 2017
Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1Jale Yuzugulen, Julie A Douthwaite, Elizabeth G Wood, et al.
The Journal of Biological Chemistry|May 24, 2014
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entryJun Jin, Philippe Colin, Isabelle Staropoli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2016
Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and AdjuvantsElodie Belnoue, Wilma Di Berardino-Besson, Hubert Gaertner, et al.
Frontiers in Immunology|April 17, 2023
C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonatesMaria Vono, Beatris Mastelic-Gavillet, Elodie Mohr, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Protein Engineering, Design & Selection : PEDS|January 8, 2008
Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4Hubert Gaertner, Olivier Lebeau, Irène Borlat, et al.
Biophysical Journal|August 19, 2019
High-Affinity Binding of Chemokine Analogs that Display Ligand Bias at the HIV-1 Coreceptor CCR5Carlos A Rico, Yamina A Berchiche, Mizuho Horioka, et al.
Science (New York, N.Y.)|October 16, 2004
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5Michael M Lederman, Ronald S Veazey, Robin Offord, et al.
Clinical & Translational Immunology|December 21, 2020
Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general populationNicolas Vuilleumier, Panagiotis Antiochos, Pedro Marques-Vidal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2023
Influenza A virus exploits transferrin receptor recycling to enter host cellsBeryl Mazel-Sanchez, Chengyue Niu, Nathalia Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2004
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitorsOliver Hartley, Hubert Gaertner, Jill Wilken, et al.
Scientific Reports|July 12, 2017
Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1Jale Yuzugulen, Julie A Douthwaite, Elizabeth G Wood, et al.
The Journal of Biological Chemistry|May 24, 2014
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entryJun Jin, Philippe Colin, Isabelle Staropoli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2016
Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and AdjuvantsElodie Belnoue, Wilma Di Berardino-Besson, Hubert Gaertner, et al.
Frontiers in Immunology|April 17, 2023
C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonatesMaria Vono, Beatris Mastelic-Gavillet, Elodie Mohr, et al.
Pageof 9